Payden & Rygel’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.8M | Hold |
198,100
| – | – | 1.83% | 10 |
|
|
2025
Q4 | $20.9M | Buy |
198,100
+190
| +0.1% | +$17.8K | 1.44% | 19 |
|
|
2025
Q3 | $16.6M | Buy |
197,910
+194,200
| +5,235% | +$16M | 1.38% | 32 |
|
|
2025
Q2 | $294K | Sell |
3,710
-3,700
| -50% | -$294K | 0.02% | 91 |
|
|
2025
Q1 | $665K | Sell |
7,410
-104,140
| -93% | -$9.72M | 0.06% | 89 |
|
|
2024
Q4 | $11.1M | Sell |
111,550
-73,600
| -40% | -$7.59M | 0.96% | 53 |
|
|
2024
Q3 | $21M | Buy |
185,150
+65,000
| +54% | +$7.72M | 1.62% | 17 |
|
|
2024
Q2 | $14.9M | Sell |
120,150
-11,600
| -9% | -$1.49M | 1.2% | 41 |
|
|
2024
Q1 | $17.4M | Sell |
131,750
-35,100
| -21% | -$4.33M | 0.82% | 39 |
|
|
2023
Q4 | $18.2M | Hold |
166,850
| – | – | 1.26% | 31 |
|
|
2023
Q3 | $17.2M | Sell |
166,850
-29,100
| -15% | -$3.14M | 1.17% | 26 |
|
|
2023
Q2 | $22.6M | Sell |
195,950
-43,850
| -18% | -$4.98M | 1.6% | 16 |
|
|
2023
Q1 | $25.5M | Sell |
239,800
-98,210
| -29% | -$10.6M | 1.51% | 21 |
|
|
2022
Q4 | $37.5M | Sell |
338,010
-66,200
| -16% | -$6.77M | 2% | 10 |
|
|
2022
Q3 | $34.8M | Buy |
404,210
+216,800
| +116% | +$19.4M | 2.04% | 8 |
|
|
2022
Q2 | $17.1M | Buy |
187,410
+184,000
| +5,396% | +$16.3M | 1.03% | 52 |
|
|
2022
Q1 | $280K | Hold |
3,410
| – | – | 0.01% | 108 |
|
|
2021
Q4 | $261K | Sell |
3,410
-477,100
| -99% | -$38M | 0.01% | 110 |
|
|
2021
Q3 | $36.1M | Buy |
480,510
+58,900
| +14% | +$4.48M | 1.87% | 9 |
|
|
2021
Q2 | $32.8M | Sell |
421,610
-22,543
| -5% | -$1.68M | 1.56% | 19 |
|
|
2021
Q1 | $32.7M | Buy |
444,153
+133,201
| +43% | +$9.83M | 1.52% | 26 |
|
|
2020
Q4 | $24.3M | Sell |
310,952
-148,921
| -32% | -$11.4M | 1.24% | 42 |
|
|
2020
Q3 | $36.4M | Buy |
459,873
+20,331
| +5% | +$1.59M | 2.16% | 7 |
|
|
2020
Q2 | $32.4M | Sell |
439,542
-152,054
| -26% | -$11.4M | 2.07% | 11 |
|
|
2020
Q1 | $43.4M | Buy |
591,596
+52,316
| +10% | +$4.11M | 3.13% | 3 |
|
|
2019
Q4 | $46.8M | Sell |
539,280
-2,410
| -0.4% | -$198K | 2.93% | 1 |
|
|
2019
Q3 | $43.5M | Buy |
541,690
+16,118
| +3% | +$1.29M | 2.96% | 1 |
|
|
2019
Q2 | $42.1M | Buy |
525,572
+15,301
| +3% | +$1.17M | 2.88% | 3 |
|
|
2019
Q1 | $40.5M | Hold |
510,271
| – | – | 2.96% | 2 |
|
|
2018
Q4 | $37.2M | Buy |
510,271
+11,423
| +2% | +$806K | 3% | 2 |
|
|
2018
Q3 | $33.8M | Sell |
498,848
-38,252
| -7% | -$2.44M | 2.57% | 4 |
|
|
2018
Q2 | $31.1M | Hold |
537,100
| – | – | 2.45% | 7 |
|
|
2018
Q1 | $27.9M | Buy |
537,100
+168,518
| +46% | +$9.1M | 2.27% | 7 |
|
|
2017
Q4 | $19.8M | Hold |
368,582
| – | – | 1.72% | 18 |
|
|
2017
Q3 | $22.5M | Sell |
368,582
-69,587
| -16% | -$4.22M | 2.24% | 8 |
|
|
2017
Q2 | $26.8M | Buy |
438,169
+10,375
| +2% | +$632K | 2.34% | 6 |
|
|
2017
Q1 | $25.9M | Buy |
427,794
+11,528
| +3% | +$699K | 2.37% | 6 |
|
|
2016
Q4 | $23.4M | Hold |
416,266
| – | – | 2.16% | 8 |
|
|
2016
Q3 | $24.8M | Buy |
416,266
+51,248
| +14% | +$3M | 2.48% | 6 |
|
|
2016
Q2 | $20.1M | Sell |
365,018
-610
| -0.2% | -$32.5K | 2.28% | 10 |
|
|
2016
Q1 | $18.5M | Buy |
365,628
+39,928
| +12% | +$1.96M | 2.25% | 12 |
|
|
2015
Q4 | $16.4M | Buy |
325,700
+58,879
| +22% | +$2.97M | 2.17% | 11 |
|
|
2015
Q3 | $12.6M | Sell |
266,821
-325
| -0.1% | -$17.3K | 1.81% | 22 |
|
|
2015
Q2 | $14.5M | Hold |
267,146
| – | – | 1.92% | 18 |
|
|
2015
Q1 | $14.7M | Buy |
267,146
+86,775
| +48% | +$4.91M | 1.91% | 16 |
|
|
2014
Q4 | $9.77M | Sell |
180,371
-43,911
| -20% | -$2.45M | 1.87% | 16 |
|
|
2014
Q3 | $12.7M | Buy |
224,282
+31,544
| +16% | +$1.77M | 2.51% | 4 |
|
|
2014
Q2 | $10.6M | Buy |
192,738
+56,068
| +41% | +$3.06M | 2.69% | 3 |
|
|
2014
Q1 | $7.4M | Buy |
136,670
+220
| +0.2% | +$11.4K | 2.88% | 2 |
|
|
2013
Q4 | $6.52M | Hold |
136,450
| – | – | 2.22% | 8 |
|
|
2013
Q3 | $6.2M | Sell |
136,450
-9,851
| -7% | -$450K | 2.21% | 5 |
|
|
2013
Q2 | $6.48M | Buy |
+146,301
| New | +$6.53M | 2.53% | 5 |
|
Other funds holding MRK
VCM
VPM
Payden & Rygel's MRK Position: Q1 2026 in Review
Payden & Rygel held its Merck (MRK) position steady in Q1 2026 at 198,100 shares worth $23.8M. The position accounts for 1.83% of the portfolio, ranked #10.
Payden & Rygel first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $46.8M in Q4 2019. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Payden & Rygel held 198,100 shares of Merck worth $23.8M as of Q1 2026.
- Payden & Rygel left its Merck share count unchanged in Q1 2026.
- Merck made up 1.83% of Payden & Rygel's portfolio in Q1 2026, its #10 holding.
- Payden & Rygel first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Payden & Rygel's Merck position peaked at $46.8M in Q4 2019.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Payden & Rygel's 13F filing for Q1 2026, filed 12 May 2026.